(Companies: Teva Pharmaceuticals, Mylan NV, Sandoz International GmbH, Hospira (Pfizer Inc.) and Sun Pharmaceutical)
The global generic pharmaceuticals market is expected to grow to $309.16 billion at a rate of about 9.3% through 2022. The rising incidence of chronic diseases is one of the major drivers of the generic pharmaceuticals market. As more individuals are diagnosed with chronic diseases, they look for more medicines for the treatment. Branded drugs come at a premium price, while generic drugs are available at a lower cost having the same chemical composition of branded drugs. The low cost and same chemical composition and strength of generic drugs make a patient buy generic drugs instead of branded drugs. If it is a chronic disease, the treatment goes for a longer period of time and hence, the sales of generic drugs also increase.
The global generic pharmaceuticals market was valued at about $216.94 billion in 2018. The North American region has the largest market share in the generic pharmaceuticals market. View More @ https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report
A generic medicine is a medication designed to be identical as branded drugs marketed by private companies in dosage form, strength, safety, route of administration, performance characteristics, quality, and intended use. Generic drugs work in the same way as branded drugs in terms of clinical benefits. Generic drugs are manufactured after the expiration of the exclusive rights or patent of the branded drugs.
The lack of awareness about generic drugs is one of the restraints on the generic pharmaceuticals market. 3D printing technology has the ability to transform the manufacturing of drugs in the generic pharmaceuticals market. 3D printed pharmaceuticals helps in improve R&D productivity and deliver new benefits to patients. 3D printing allows the manufacturer to produce drugs with customized size, shape, and texture which is not possible in traditional manufacturing of generic drugs. 3D printing can help the manufacturer to make generic drugs that have different release dates, appearances and taste.
Major players in the market are Teva Pharmaceuticals, Mylan NV, Sandoz International GmbH, Hospira (Pfizer Inc.) and Sun Pharmaceutical. Sun Pharma is the fourth largest global specialty generic pharmaceutical company in the world and Number 1 in India.
Request a Sample @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2479&type=smp
3D printing technology has the ability to transform the manufacturing of drugs in the generic pharmaceuticals market. 3D printed pharmaceuticals helps in improve R&D productivity and deliver new benefits to patients. 3D printing allows the manufacturer to produce drugs with customized size, shape, and texture which is not possible in traditional manufacturing of generic drugs. 3D printing can help the manufacturer to make generic drugs that have different release dates, appearances and taste. For example, in 2017, GlaxoSmithKline (GSK) completed a study where ultraviolet (UV) and 3D printing were used to manufacture tablets to treat Parkinson’s disease. Martin Wallace, director of GSK Technology, said that GSK is investing in 3D printing advantages to manufacture pills and tablets. Also, in 2015, Aprecia pharmaceutical company launched ‘ZipDose’ technology which manufactures 3D printed drugs.
Few Points From Table of Contents:
1. Executive Summary
2. Generic Pharmaceuticals Market Characteristics
3. Generic Pharmaceuticals Market Size And Growth
4. Generic Pharmaceuticals Market Segmentation
4.1. Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
CNS
Cardiovascular
Dermatology
Genitourinary/Harmonal
Respiratory
Rheumatology
Diabetes
Oncology
4.2. Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
4.3. Global Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
Biosimilar
Simple Generic
Super Generic
4.4. Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
Oral
Inectables
Dermal/Topical
Inhaler
5. Generic Pharmaceuticals Market Regional And Country Analysis
Order a Copy of Complete Report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2479
About The Business Research Company:
The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Media Contact
Company Name: The Business Research Company
Contact Person: Nitin
Email: Send Email
Phone: 08897263534
Address:1st Floor, Anshu Colors Building, Road Number 1 Park View Enclave, Jubilee Hills
City: Hyderabad 500033
State: Telengana
Country: India
Website: https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report